Last mentioned: Mar 21, 2026
Annual Results Announcement
Official report confirms a retreat in full-year net income compared to the previous fiscal year.
VBP Participation
Company participates in multi-province centralized procurement for intraocular lenses, securing volume at lower price points.
Aesthetics Expansion
Haohai launches new line of high-end dermal fillers to compete in the premium aesthetics market.
Shanghai Haohai Biological Technology Co., Ltd. has reported a decline in full-year income for the 2025 fiscal year, driven by margin compression in its core ophthalmology and orthopedic segments. The retreat highlights the ongoing challenges of China's volume-based procurement (VBP) policies and intensifying competition in the medical aesthetics market.
This page surfaces every story mentioning Shanghai Haohai Biological Technology Co., Ltd across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Shanghai Haohai Biological Technology Co., Ltd was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |